Innovating Works

AGENCIA ESPAÑOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS

Inactiva
ERAMET: Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the... UNIVERSITE DE NAMUR ASBL tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 ERAMET will provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the dr...
2023-11-17 - 2027-12-31 | Financiado
Gravitate-Health: Gravitate Health Empowering and Equipping Europeans with health information for Active Personal Hea... The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsiv...
2020-11-12 - 2025-10-31 | Financiado
HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY PLUS FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON tramitó un H2020: H2020-JTI-IMI2-2019-19-single-stage Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be e...
2020-05-26 - 2024-03-31 | Financiado
UNICOM: Up scaling the global univocal identification of medicines EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH tramitó un H2020: H2020-SC1-DTH-2018-2020 This innovation action will give a powerful impulse to implementation of ISO IDMP (ID of Medicinal Products) standards in EU Member States d...
2019-11-11 - 2024-05-31 | Financiado
STARS: Strengthening training of academia in regulatory sciences and supporting regulatory scientific advic... BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE tramitó un H2020: H2020-SC1-BHC-2018-2020 Lack of specific relevant know-how in regulatory science delays the development of new treatment strategies or limits the chances that promi...
2018-11-20 - 2022-06-30 | Financiado
WEB-RADR 2: WEB RADR 2 TOUCH TD LTD tramitó un H2020: H2020-JTI-IMI2-2017-11-single-stage This proposal seeks to build on the mobile application (app) functionality delivered through the original WEB-RADR project to expand access...
2018-09-10 - 2020-06-30 | Financiado
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY Sofia ref.... FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON tramitó un H2020: H2020-JTI-IMI2-2015-06-two-stage Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in qual...
2016-12-22 - 2023-06-30 | Financiado
openMedicine: openMedicine EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH tramitó un H2020: H2020-PHC-2014-2015 The CSA will enhance the safety of cross-border healthcare through interoperable ePrescriptions. epSOS solved the message transfer problem,...
2014-12-11 - 2016-12-31 | Financiado
ADVANCE: Accelerated Development of Vaccine benefit-risk Collaboration in Europe P95 CVBA tramitó un FP6: Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to...
2013-10-01 - 2019-03-31 | Financiado
SAFEGUARD: Safety Evaluation of Adverse Reactions in Diabetes ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM tramitó un FP7: "In 2010 a widely marketed drug for the treatment of type 2 diabetes (T2DM) (rosiglitazone) was taken from the market as it was associated w...
Financiado
ECRIN-PPI: European clinical research infrastructures network for clinical trials and biotherapy preparatory... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un FP7: European clinical research needs an integrated and distributed infrastructure able to provide efficient support to multinational clinical tr...
Financiado
PROTECT: Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium THE EUROPEAN MEDICINES AGENCY tramitó un FP7: Recent pharmacovigilance (PV) issues have led to questions regarding the ability of the current PV system to meet the global needs. Controve...
Financiado
ADVANCE: Accelerated Development of Vaccine benefit risk Collaboration in Europe P95 CVBA tramitó un FP7: Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.